Your Article Summary
See Latest ArticlesSafety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
Antimicrobial Agents and Chemotherapy, 06/29/09
Spellberg B et al. - Deferasirox was administered for an average of 14 days at 5 to 20 mg/kg of body weight/day. Deferasirox treatment was not associated with changes in renal or liver function, complete blood count, or transplant immunosuppressive levels. Thus, deferasirox appears safe as an adjunctive therapy for mucormycosis.
Related Articles
A Successful Combined Endovascular and Surgical Treatment of A Cranial Base Mucormycosis With An Associated Internal Carotid Artery Pseudoaneurysm
Neurosurgery, 10/07/09
Relevance Score: 88%
Rhino-Orbital-Cerebral Mucormycosis: A Lethal Complication of Body Dysmorphic Disorder
Ophthalmic Plastic and Reconstructive Surgery, 10/06/09
Relevance Score: 83%
Ulcerative leg nodules in a transplant recipient
Cleveland Clinic Journal of Medicine, 10/16/09
Relevance Score: 82%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
Intensive Care Medicine, 12/09/09
Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09
Today in Fungal Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09
Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy
Clinical Infectious Diseases, 12/08/09
Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection
International Immunology, 12/07/09